Introduction: Androgenetic alopecia, commonly known as male or female pattern hair loss, is a prevalent form of hair loss affecting millions worldwide. Traditionally managed by medications like minoxidil and finasteride, a few studies suggest ketoconazole shampoo may also play a significant role in managing this condition. This article explores the efficacy, mechanism, and application of ketoconazole shampoo in the treatment of androgenetic alopecia.
Understanding Androgenetic Alopecia: Androgenetic alopecia is characterized by the progressive thinning of hair in a patterned manner. The condition is largely influenced by genetic predisposition and hormonal levels, particularly dihydrotestosterone (DHT), a derivative of testosterone. DHT’s interaction with hair follicle receptors gradually miniaturizes the follicles, leading to thinner, shorter hair. More details are presented in other articles on this website.
Ketoconazole – From Antifungal to Hair Loss Management: Ketoconazole was originally developed as an antifungal agent used to treat dandruff and other fungal infections of the scalp. It is available in various formulations, with the 1-2% shampoo being the most common for scalp application widely available in pharmacies. Higher concentration shampoos are available on prescription. Although ketoconazole shampoos were originally developed for their antifungal properties, ketoconazole has exhibited potential benefits in treating hair loss, particularly androgenetic alopecia.
Mechanism of Action: It’s actually not entirely clear how ketoconazole works, but the beneficial effects are probably due to these properties:
Anti-Androgenic Properties: Ketoconazole’s role in hair loss treatment is partially attributed to its direct anti-androgenic effects. Studies suggest that ketoconazole can disrupt the DHT pathway. By inhibiting the binding of DHT to androgen receptors in the hair follicle, ketoconazole may reduce the hair follicle’s exposure to DHT. Consequently, this interference helps minimize DHTs deleterious effects.Anti-Inflammatory Effects: Inflammation probably plays a role in androgenetic alopecia; at least for some people. Ketoconazole is thought to exert anti-inflammatory effects through inhibition of 5-lipooxygase. Ketoconazole’s anti-inflammatory properties help reduce scalp inflammation, a contributing factor to hair follicle miniaturization. By mitigating inflammation, ketoconazole shampoo can potentially enhance the general health and environment of the hair follicles.Sebum Reduction: Excessive scalp sebum can exacerbate hair loss in individuals with androgenetic alopecia. Ketoconazole has been shown to reduce sebum production, which may help in decreasing the scalp conditions that contribute to hair loss.Clinical Evidence: A few studies (though not many) have investigated the effectiveness of ketoconazole as a treatment for hair loss. A notable study compared ketoconazole 2% shampoo with unmedicated shampoos and found that subjects using ketoconazole showed improvements in hair density and hair fiber size. Users also showed a reduction in sebum production and inflammation. Moreover, when used in conjunction with other treatments like minoxidil, ketoconazole has been shown to synergistically enhance hair growth outcomes. At least one study of ketoconazole in mice has indicated a more direct hair growth promoting effect may also be present. As the mouse hair follicles were androgen insensitive, the authors concluded that ketoconazole has additional direct effects on androgen insensitive hair growth.
Usage Guidelines: For those considering ketoconazole shampoo for androgenetic alopecia, several medical journal articles suggest variations on this protocol:
Frequency: Initially, apply the shampoo two to three times a week. Once there is improvement in sebum production, reduce usage to once a week.Application: Apply the shampoo to the damp scalp, and lather it well. Leave it on the scalp for 3-5 minutes before rinsing thoroughly.Duration: Regular use is essential as the benefits of ketoconazole shampoo can diminish once the treatment is discontinued.Safety and Side Effects: Ketoconazole shampoo is generally well tolerated. However, potential side effects can include local skin irritation, dryness of the scalp, and rare allergic reactions. Patients are advised to consult with a healthcare provider before starting any new treatment for androgenetic alopecia.
Combining Treatments: Ketoconazole shampoo has been used in combination with other treatments. Over-the-counter topical treatment minoxidil, and prescription oral medication finasteride, are commonly prescribed alongside ketoconazole for enhanced results.
Conclusion: Ketoconazole shampoo presents a promising, multifaceted approach in the management of androgenetic alopecia. Its anti-androgenic, anti-inflammatory, and sebum-reducing properties make it a valuable addition to hair loss treatment regimens. While not a cure, ketoconazole can significantly aid in the control and management of hair loss when used appropriately. As with any medical treatment, consultation with a healthcare professional is crucial to ensure safety and efficacy. Continued research and clinical trials will further elucidate the role of ketoconazole in treating hair loss and help refine treatment protocols for androgenetic alopecia.
Bibliography
11711645 {11711645:KW873MTS},{11711645:5VXPQES7},{11711645:VATJI9I8},{11711645:I5FVJDSJ},{11711645:NDDCR8UA},{11711645:BGP37FQT},{11711645:ISBD2Q2Z},{11711645:F9ZUNDUM},{11711645:PBXTR48P},{11711645:3WE4B69Z},{11711645:B7AR9Q7C} 1 vancouver 50 date asc 1483 https://www.keratin.com/wp-content/plugins/zotpress/ %7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22I5FVJDSJ%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Borgers%20et%20al.%22%2C%22parsedDate%22%3A%221983-01-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBorgers%20M%2C%20Van%20den%20Bossche%20H%2C%20De%20Brabander%20M.%20The%20mechanism%20of%20action%20of%20the%20new%20antimycotic%20ketoconazole.%20Am%20J%20Med.%201983%20Jan%2024%3B74%281B%29%3A2%26%23x2013%3B8.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20mechanism%20of%20action%20of%20the%20new%20antimycotic%20ketoconazole%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Borgers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Van%20den%20Bossche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22De%20Brabander%22%7D%5D%2C%22abstractNote%22%3A%22Ketoconazole%20is%20one%20of%20the%20new%20members%20of%20the%20imidazole%20series%20with%20a%20broad-spectrum%20antifungal%20profile.%20Although%20sharing%20its%20basic%20active%20principles%20with%20the%20other%20imidazoles%2C%20ketoconazole%20obtains%20its%20superior%20in%20vivo%20activity%20mainly%20from%20its%20good%20oral%20absorption%20and%20its%20lower%20degree%20of%20inactivation%20once%20absorbed.%20Its%20selective%20toxicity%20for%20yeasts%20and%20fungi%20is%20found%20to%20be%20primarily%20linked%20to%20the%20inhibition%20of%20ergosterol%20biosynthesis%20and%20to%20interference%20with%20other%20membrane%20lipids.%20In%20vitro%20growth%20studies%20revealed%20that%20ketoconazole%27s%20activity%20was%20more%20pronounced%20against%20the%20invasive%20morphogenetic%20form%20than%20against%20the%20saprophytic%20form%20of%20Candida%20albicans%2C%20which%20at%20least%20partly%20explains%20its%20prominent%20in%20vivo%20potency.%20At%20extremely%20low%20concentrations%20%2810%20ng%5C%2Fml-1%29%20ketoconazole%20prevents%20the%20development%20of%20the%20very%20form%20that%20is%20responsible%20for%20the%20expression%20of%20clinical%20symptoms.%20In%20contrast%20to%20other%20imidazoles%2C%20ketoconazole%27s%20action%20on%20the%20morphogenesis%20of%20the%20organism%20is%20not%20influenced%20by%20serum.%20The%20synergistic%20action%20with%20host%20defense%20cells%2C%20as%20demonstrated%20in%20culture%20systems%2C%20is%20another%20inherent%20property%20of%20this%20drug%20and%20may%20have%20a%20great%20impact%20on%20the%20eradication%20of%20systemic%20fungal%20infections.%20These%20effects%20of%20ketoconazole%20have%20been%20studied%20in%20a%20variety%20of%20fungal%20organisms%20with%20the%20aid%20of%20phase-contrast%2C%20scanning%2C%20and%20transmission%20electron%20microscopy%20in%20order%20to%20characterize%20ketoconazole%27s%20profile%20in%20comparison%20to%20the%20other%20imidazole%20derivatives.%22%2C%22date%22%3A%221983-01-24%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2F0002-9343%2883%2990507-7%22%2C%22ISSN%22%3A%220002-9343%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-01T15%3A00%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22B7AR9Q7C%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sawaya%20et%20al.%22%2C%22parsedDate%22%3A%221989-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3ESawaya%20ME%2C%20Honig%20LS%2C%20Hsia%20SL.%20Increased%20androgen%20binding%20capacity%20in%20sebaceous%20glands%20in%20scalp%20of%20male-pattern%20baldness.%20J%20Invest%20Dermatol.%201989%20Jan%3B92%281%29%3A91%26%23x2013%3B5.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Increased%20androgen%20binding%20capacity%20in%20sebaceous%20glands%20in%20scalp%20of%20male-pattern%20baldness%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20E.%22%2C%22lastName%22%3A%22Sawaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20S.%22%2C%22lastName%22%3A%22Honig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20L.%22%2C%22lastName%22%3A%22Hsia%22%7D%5D%2C%22abstractNote%22%3A%22Sebaceous%20glands%20were%20isolated%20by%20manual%20dissection%20under%20a%20microscope%20from%20surgical%20specimens%20of%20scalp%20skin%20with%20male%20pattern%20baldness%20and%20skin%20specimens%20of%20hairy%20and%20bald%20scalp%20obtained%20at%20autopsy.%20The%20800%20X%20g%20pellet%20%28nuclear%20fraction%29%20and%20the%20164%2C000%20X%20g%20supernatant%20fraction%20%28cytosol%29%20of%20homogenates%20of%20the%20sebaceous%20glands%20were%20used%20for%20measurements%20of%20androgen%20binding%20characteristics%2C%20using%20dextran-coated%20charcoal%20and%20sucrose%20gradient%20methods.%20Scatchard%20plots%20showed%20high%20affinity%20binding%20for%20%5B3H%5Ddihydrotestosterone%20%28DHT%29%20and%20%5B3H%5Dmethyltrienolone%20%28R1881%29.%20Nuclei%20prepared%20from%20bald%20scalp%20contained%20greater%20total%20androgen%20binding%20capacity%20than%20nuclei%20of%20hairy%20scalp%2C%20although%20Kd%20values%20of%20type%20I%20binding%20were%20similar%20%280.68%20vs%200.56%20nM%2C%20respectively%29.%20On%20sucrose%20gradient%2C%20the%20binding%20protein%20from%20cytosol%20was%20found%20in%20the%207%20to%208S%20density%20range.%20Androgen%20binding%20by%20cytosol%20of%20sebaceous%20glands%20of%20hairy%20scalp%20had%20Kd%20of%201.89%20%2B%5C%2F-%20.79%20and%202.05%20%2B%5C%2F-%20.56%20nM%20for%20DHT%20and%20R1881%2C%20respectively%2C%20and%20Bmax%20of%2018.7%20%2B%5C%2F-%204.4%20and%2020.0%20%2B%5C%2F-%204.6%20fmol%5C%2Fmg%20protein%20for%20DHT%20and%20R1881%2C%20respectively.%20Cytosol%20from%20sebaceous%20glands%20of%20bald%20scalp%20had%20Kd%20values%20approximately%20half%20those%20of%20hairy%20scalp%2C%20and%20Bmax%20values%2050%25-100%25%20higher.%20The%20bound%203H%20labeled%20DHT%20and%20R1881%20could%20be%20partially%20displaced%20by%20testosterone%20%2840-50%25%29%2C%20moxestrol%20%2828-32%25%29%2C%20promegestone%20%2819-26%25%29%2C%20and%20delta%204-androstenedione%20%286-12%25%29%2C%20but%20not%20by%20dehydroepiandrosterone.%20These%20data%20demonstrate%20the%20presence%20of%20specific%20androgen%20binding%20protein%20in%20sebaceous%20glands%2C%20and%20that%20sebaceous%20glands%20of%20bald%20scalp%20have%20greater%20binding%20affinity%20and%20capacity%20for%20androgens%20than%20those%20in%20hairy%20scalp.%20This%20difference%20may%20explain%20the%20greater%20androgenic%20response%20in%20androgenic%20alopecia.%22%2C%22date%22%3A%221989-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2F1523-1747.ep13071290%22%2C%22ISSN%22%3A%220022-202X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-01T14%3A57%3A18Z%22%7D%7D%2C%7B%22key%22%3A%223WE4B69Z%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Pi%5Cu00e9rard-Franchimont%20et%20al.%22%2C%22parsedDate%22%3A%221998%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EPi%26%23xE9%3Brard-Franchimont%20C%2C%20De%20Doncker%20P%2C%20Cauwenbergh%20G%2C%20Pi%26%23xE9%3Brard%20GE.%20Ketoconazole%20shampoo%3A%20effect%20of%20long-term%20use%20in%20androgenic%20alopecia.%20Dermatology.%201998%3B196%284%29%3A474%26%23x2013%3B7.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ketoconazole%20shampoo%3A%20effect%20of%20long-term%20use%20in%20androgenic%20alopecia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Pi%5Cu00e9rard-Franchimont%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22De%20Doncker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Cauwenbergh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20E.%22%2C%22lastName%22%3A%22Pi%5Cu00e9rard%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20pathogenesis%20of%20androgenic%20alopecia%20is%20not%20fully%20understood.%20A%20microbial-driven%20inflammatory%20reaction%20abutting%20on%20the%20hair%20follicles%20might%20participate%20in%20the%20hair%20status%20anomaly.%5CnOBJECTIVE%3A%20The%20aim%20of%20our%20study%20was%20to%20determine%20if%20ketoconazole%20%28KCZ%29%20which%20is%20active%20against%20the%20scalp%20microflora%20and%20shows%20some%20intrinsic%20anti-inflammatory%20activity%20might%20improve%20alopecia.%5CnMETHOD%3A%20The%20effect%20of%202%25%20KCZ%20shampoo%20was%20compared%20to%20that%20of%20an%20unmedicated%20shampoo%20used%20in%20combination%20with%20or%20without%202%25%20minoxidil%20therapy.%5CnRESULTS%3A%20Hair%20density%20and%20size%20and%20proportion%20of%20anagen%20follicles%20were%20improved%20almost%20similarly%20by%20both%20KCZ%20and%20minoxidil%20regimens.%20The%20sebum%20casual%20level%20appeared%20to%20be%20decreased%20by%20KCZ.%5CnCONCLUSION%3A%20Comparative%20data%20suggest%20that%20there%20may%20be%20a%20significant%20action%20of%20KCZ%20upon%20the%20course%20of%20androgenic%20alopecia%20and%20that%20Malassezia%20spp.%20may%20play%20a%20role%20in%20the%20inflammatory%20reaction.%20The%20clinical%20significance%20of%20the%20results%20awaits%20further%20controlled%20study%20in%20a%20larger%20group%20of%20subjects.%22%2C%22date%22%3A%221998%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1159%5C%2F000017954%22%2C%22ISSN%22%3A%221018-8665%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-01T14%3A56%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22PBXTR48P%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Khandpur%20et%20al.%22%2C%22parsedDate%22%3A%222002-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EKhandpur%20S%2C%20Suman%20M%2C%20Reddy%20BS.%20Comparative%20efficacy%20of%20various%20treatment%20regimens%20for%20androgenetic%20alopecia%20in%20men.%20J%20Dermatol.%202002%20Aug%3B29%288%29%3A489%26%23x2013%3B98.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparative%20efficacy%20of%20various%20treatment%20regimens%20for%20androgenetic%20alopecia%20in%20men%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sujay%22%2C%22lastName%22%3A%22Khandpur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mansi%22%2C%22lastName%22%3A%22Suman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Belum%20Sivanagi%22%2C%22lastName%22%3A%22Reddy%22%7D%5D%2C%22abstractNote%22%3A%22Our%20understanding%20of%20the%20aetiology%20of%20androgenetic%20alopecia%20%28AGA%29%20has%20substantially%20increased%20in%20recent%20years.%20As%20a%20result%2C%20several%20treatment%20modalities%20have%20been%20tried%20with%20promising%20results%20especially%20in%20early%20stages%20of%20AGA.%20However%2C%20as%20far%20as%20has%20been%20ascertained%2C%20there%20is%20no%20comprehensive%20study%20comparing%20the%20efficacy%20of%20these%20agents%20alone%20and%20in%20combination%20with%20each%20other.%20One%20hundered%20male%20patients%20with%20AGA%20of%20Hamilton%20grades%20II%20to%20IV%20were%20enrolled%20in%20an%20open%2C%20randomized%2C%20parallel-group%20study%2C%20designed%20to%20evaluate%20and%20compare%20the%20efficacy%20of%20oral%20finasteride%20%281%20mg%20per%20day%29%2C%20topical%202%25%20minoxidil%20solution%20and%20topical%202%25%20ketoconazole%20shampoo%20alone%20and%20in%20combination.%20They%20were%20randomized%20into%20four%20groups.%20Group%20I%20%2830%20patients%29%20was%20administered%20oral%20finasteride%2C%20Group%20II%20%2836%20patients%29%20was%20given%20a%20combination%20of%20finasteride%20and%20topical%20minoxidil%2C%20Group%20III%20%2824%20patients%29%20applied%20minoxidil%20alone%20and%20Group%20IV%20%2810%20patients%29%20was%20administered%20finasteride%20with%20topical%20ketoconazole.%20Treatment%20efficacy%20was%20assessed%20on%20the%20basis%20of%20patient%20and%20physician%20assessment%20scores%20and%20global%20photographic%20review%20during%20the%20study%20period%20of%20one%20year.%20At%20the%20end%20of%20one%20year%2C%20hair%20growth%20was%20observed%20in%20all%20the%20groups%20with%20best%20results%20recorded%20with%20a%20combination%20of%20finasteride%20and%20minoxidil%20%28Group%20II%29%20followed%20by%20groups%20IV%2C%20I%20and%20III.%20Subjects%20receiving%20finasteride%20alone%20or%20in%20combination%20with%20minoxidil%20or%20ketoconazole%20showed%20statistically%20significant%20improvement%20%28p%3C0.05%29%20over%20minoxidil%20only%20recipients.%20No%20signifcant%20side-effects%20related%20to%20the%20drugs%20were%20observed.%20In%20conclusion%2C%20it%20is%20inferred%20that%20the%20therapeutic%20efficacy%20is%20enhanced%20by%20combining%20the%20two%20drugs%20acting%20on%20different%20aetiological%20aspects%20of%20AGA.%22%2C%22date%22%3A%222002-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fj.1346-8138.2002.tb00314.x%22%2C%22ISSN%22%3A%220385-2407%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-01T14%3A52%3A23Z%22%7D%7D%2C%7B%22key%22%3A%22BGP37FQT%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hugo%20Perez%22%2C%22parsedDate%22%3A%222004%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHugo%20Perez%20BS.%20Ketocazole%20as%20an%20adjunct%20to%20finasteride%20in%20the%20treatment%20of%20androgenetic%20alopecia%20in%20men.%20Med%20Hypotheses.%202004%3B62%281%29%3A112%26%23x2013%3B5.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Ketocazole%20as%20an%20adjunct%20to%20finasteride%20in%20the%20treatment%20of%20androgenetic%20alopecia%20in%20men%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20S.%22%2C%22lastName%22%3A%22Hugo%20Perez%22%7D%5D%2C%22abstractNote%22%3A%22Dihydrotestosterone%20%28DHT%29%20binding%20to%20androgen%20receptors%20%28AR%29%20in%20hair%20follicles%20is%20commonly%20accepted%20as%20the%20first%20step%20leading%20to%20the%20miniaturizing%20of%20follicles%20associated%20with%20androgenetic%20alopecia%20%28AGA%29.%20Testosterone%20is%20converted%20to%20DHT%20by%20the%20enzyme%205alpha-reductase.%20Finasateride%20a%205alpha-reducase%20inhibitor%20blocks%20the%20production%20of%20DHT%20and%20is%20currently%20used%20to%20treat%20AGA.%20The%20inhibition%20is%20not%20complete%20but%20a%20reduction%20of%20DHT%20systemically%20and%20in%20the%20scalp%20is%20accomplished.%20Ketoconazole%20has%20been%20clinically%20shown%20to%20be%20effective%20in%20the%20treatment%20of%20AGA.%20In%20this%20paper%2C%20evidence%20is%20presented%20to%20support%20the%20hypothesis%20that%20ketoconazole%202%25%20shampoo%20has%20a%20local%20disruption%20of%20the%20DHT%20pathway.%20It%20is%20proposed%20that%20using%20ketoconazole%202%25%20shampoo%20as%20an%20adjunct%20to%20finasteride%20treatment%20could%20lead%20to%20a%20more%20complete%20inhibition%20of%20DHT%20and%20thus%20better%20treat%20AGA.%22%2C%22date%22%3A%222004%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fs0306-9877%2803%2900264-0%22%2C%22ISSN%22%3A%220306-9877%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-01T14%3A50%3A54Z%22%7D%7D%2C%7B%22key%22%3A%22F9ZUNDUM%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jiang%20et%20al.%22%2C%22parsedDate%22%3A%222005-04%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EJiang%20J%2C%20Tsuboi%20R%2C%20Kojima%20Y%2C%20Ogawa%20H.%20Topical%20application%20of%20ketoconazole%20stimulates%20hair%20growth%20in%20C3H%5C%2FHeN%20mice.%20J%20Dermatol.%202005%20Apr%3B32%284%29%3A243%26%23x2013%3B7.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Topical%20application%20of%20ketoconazole%20stimulates%20hair%20growth%20in%20C3H%5C%2FHeN%20mice%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ju%22%2C%22lastName%22%3A%22Jiang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryoji%22%2C%22lastName%22%3A%22Tsuboi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuko%22%2C%22lastName%22%3A%22Kojima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hideoki%22%2C%22lastName%22%3A%22Ogawa%22%7D%5D%2C%22abstractNote%22%3A%22Ketoconazole%20%28KCZ%29%20is%20an%20imidazole%20anti-fungal%20agent%20that%20is%20also%20effective%20in%20topical%20applications%20for%20treating%20seborrheic%20dermatitis%20and%20dandruff.%20Recently%2C%20topical%20use%20of%202%25%20KCZ%20shampoo%20has%20been%20reported%20to%20have%20had%20a%20clinically%20therapeutic%20effect%20on%20androgenetic%20alopecia.%20The%20present%20study%20was%20conducted%20with%20the%20purpose%20of%20quantitatively%20examining%20the%20stimulatory%20effect%20of%20KCZ%20on%20hair%20growth%20in%20a%20mouse%20model.%20Coat%20hairs%20on%20the%20dorsal%20skin%20of%20seven%20week-old%20male%20C3H%5C%2FHeN%20mice%20were%20gently%20clipped%2C%20and%20either%202%25%20KCZ%20solution%20in%2095%25%20ethanol%20or%20a%20vehicle%20solution%20was%20topically%20applied%20once%20daily%20for%20three%20weeks.%20The%20clipped%20area%20was%20photographed%2C%20and%20the%20ratio%20of%20re-grown%20coat%20area%20was%20then%20calculated.%20The%20results%20demonstrated%20that%202%25%20KCZ%20had%20a%20macroscopically%20significant%20stimulatory%20effect%20compared%20with%20the%20vehicle%20group%20%28p%3C0.01%2C%20n%3D10%29.%20Repeated%20experiments%20showed%20similar%20effects%2C%20confirming%20the%20efficacy%20of%20KCZ%20as%20a%20hair%20growth%20stimulant.%20Although%20the%20therapeutic%20mechanism%20of%20topical%20KCZ%20for%20hair%20growth%20is%20unclear%2C%20our%20results%20suggest%20that%20topical%20applications%20of%20the%20substance%20are%20useful%20for%20treating%20seborrheic%20dermatitis%20accompanied%20by%20hair%20regression%20or%20male%20pattern%20hair%20loss.%22%2C%22date%22%3A%222005-04%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fj.1346-8138.2005.tb00756.x%22%2C%22ISSN%22%3A%220385-2407%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-01T14%3A53%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22ISBD2Q2Z%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Inui%20and%20Itami%22%2C%22parsedDate%22%3A%222007-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EInui%20S%2C%20Itami%20S.%20Reversal%20of%20androgenetic%20alopecia%20by%20topical%20ketoconzole%3A%20relevance%20of%20anti-androgenic%20activity.%20J%20Dermatol%20Sci.%202007%20Jan%3B45%281%29%3A66%26%23x2013%3B8.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Reversal%20of%20androgenetic%20alopecia%20by%20topical%20ketoconzole%3A%20relevance%20of%20anti-androgenic%20activity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shigeki%22%2C%22lastName%22%3A%22Inui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satoshi%22%2C%22lastName%22%3A%22Itami%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222007-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jdermsci.2006.08.011%22%2C%22ISSN%22%3A%220923-1811%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-01T14%3A51%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22KW873MTS%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aldhalimi%20et%20al.%22%2C%22parsedDate%22%3A%222014-03-09%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAldhalimi%20MA%2C%20Hadi%20NR%2C%20Ghafil%20FA.%20Promotive%20Effect%20of%20Topical%20Ketoconazole%2C%20Minoxidil%2C%20and%20Minoxidil%20with%20Tretinoin%20on%20Hair%20Growth%20in%20Male%20Mice.%20International%20Scholarly%20Research%20Notices.%202014%20Mar%209%3B2014%3Ae575423.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Promotive%20Effect%20of%20Topical%20Ketoconazole%2C%20Minoxidil%2C%20and%20Minoxidil%20with%20Tretinoin%20on%20Hair%20Growth%20in%20Male%20Mice%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhsin%20A.%22%2C%22lastName%22%3A%22Aldhalimi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Najah%20R.%22%2C%22lastName%22%3A%22Hadi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadaa%20A.%22%2C%22lastName%22%3A%22Ghafil%22%7D%5D%2C%22abstractNote%22%3A%22Recently%20topical%20use%20of%202%25%20Ketoconazole%20solution%20has%20been%20reported%20to%20have%20a%20therapeutic%20effect%20on%20androgenic%20alopecia.%20Minoxidil%20is%20a%20vasodilatory%20medication%20used%20primarily%20as%20antihypertensive%20drug.%20It%20was%20discovered%20to%20have%20the%20side%20effect%20of%20hair%20growth%20and%20reversing%20baldness.%20Tretinoin%20is%20commonly%20used%20topically%20for%20acne%20treatment%20and%20in%20the%20treatment%20of%20photoaging.%20It%20is%20used%20by%20some%20as%20hair%20loss%20treatment.%20Objective.%20To%20compare%20the%20stimulatory%20effect%20of%20Ketoconazole%2C%20Minoxidil%2C%20and%20Minoxidil%20with%20Tretinoin%20on%20hair%20growth%20in%20a%20mouse%20model.%20Materials%20and%20Methods.%20Coat%20hairs%20on%20the%20dorsal%20skin%20of%20seven%20weeks%20old%20male%20mice%20were%20gently%20clipped%20and%20then%20stained%20by%20using%20commercial%20dye.%20These%20mice%20were%20divided%20into%20four%20groups%20each%20of%20five%20treated%20with%20topical%20application%20of%20ethanol%2095%25%2C%20Ketoconazole%20solution%202%25%2C%20Minoxidil%20solution%205%25%2C%20and%20Minoxidil%20with%20Tretinoin%20solution%200.1%25%2C%20respectively.%20The%20drugs%20were%20applied%20once%20daily%20for%20three%20weeks%2C%20the%20clipped%20area%20was%20photographed%2C%20and%20the%20ratio%20of%20regrown%20coat%20area%20was%20calculated.%20Results.%20The%20results%20demonstrated%20that%20Ketoconazole%2C%20Minoxidil%2C%20and%20Minoxidil%20with%20Tretinoin%20had%20a%20significant%20stimulatory%20effect%20on%20hair%20growth%20compared%20with%20the%20control%20group%20and%20Minoxidil%20was%20the%20most%20effective%20drug%20among%20them.%22%2C%22date%22%3A%222014%5C%2F3%5C%2F9%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1155%5C%2F2014%5C%2F575423%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-01T14%3A55%3A41Z%22%7D%7D%2C%7B%22key%22%3A%22NDDCR8UA%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Fields%20et%20al.%22%2C%22parsedDate%22%3A%222020-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EFields%20JR%2C%20Vonu%20PM%2C%20Monir%20RL%2C%20Schoch%20JJ.%20Topical%20ketoconazole%20for%20the%20treatment%20of%20androgenetic%20alopecia%3A%20A%20systematic%20review.%20Dermatol%20Ther.%202020%20Jan%3B33%281%29%3Ae13202.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Topical%20ketoconazole%20for%20the%20treatment%20of%20androgenetic%20alopecia%3A%20A%20systematic%20review%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jaime%20R.%22%2C%22lastName%22%3A%22Fields%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20M.%22%2C%22lastName%22%3A%22Vonu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reesa%20L.%22%2C%22lastName%22%3A%22Monir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%20J.%22%2C%22lastName%22%3A%22Schoch%22%7D%5D%2C%22abstractNote%22%3A%22Androgenetic%20alopecia%20%28AGA%29%20is%20common%20and%20associated%20with%20significant%20psychosocial%20distress.%20Treatment%20options%20are%20needed%20for%20patients%20that%20do%20not%20adequately%20respond%20to%20first%20line%20treatments%20of%20finasteride%20or%20minoxidil.%20Topical%20ketoconazole%20has%20been%20proposed%20as%20a%20promising%20treatment.%20The%20goal%20of%20this%20systematic%20review%20was%20to%20evaluate%20the%20efficacy%20of%20topical%20ketoconazole%20in%20the%20treatment%20of%20AGA.%20A%20systematic%20literature%20search%20was%20conducted%20within%20the%20MEDLINE%20database%20using%20the%20key%20terms%20%5C%22ketoconazole%5C%22%20and%20%5C%22alopecia.%5C%22%20Forty-seven%20papers%20were%20screened%20for%20inclusion%2C%20of%20which%20nine%20were%20assessed%20for%20eligibility.%20Seven%20articles%20were%20included%20in%20the%20qualitative%20synthesis%2C%20including%20two%20animal%20studies%20%28total%20of%2040%20participants%29%20and%20five%20human%20studies%20%28total%20of%20318%20participants%29.%20Murine%20studies%20demonstrated%20a%20significant%20increase%20in%20mean%20ratio%20of%20hair%20regrowth%20to%20denuded%20area%20in%20the%20ketoconazole%20treatment%20groups%20compared%20to%20controls.%20Human%20studies%20reported%20increased%20hair%20shaft%20diameter%20following%20ketoconazole%20use.%20One%20study%20reported%20a%20significant%20increase%20in%20pilary%20index%20%28percent%20anagen%20phase%20%5Cu00d7%20diameter%29%20following%20treatment.%20Studies%20also%20demonstrated%20clinical%20improvement%20of%20AGA%20based%20on%20photographic%20assessment%20and%20subjective%20evaluation.%20Topical%20ketoconazole%20is%20a%20promising%20adjunctive%20or%20alternative%20therapy%20in%20the%20treatment%20of%20AGA.%20Randomized%20controlled%20trials%20are%20needed.%22%2C%22date%22%3A%222020-01%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fdth.13202%22%2C%22ISSN%22%3A%221529-8019%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-01T14%3A53%3A40Z%22%7D%7D%2C%7B%22key%22%3A%22VATJI9I8%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anastassakis%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAnastassakis%20K.%20Ketoconazole.%20In%3A%20Anastassakis%20K%2C%20editor.%20Androgenetic%20Alopecia%20From%20A%20to%20Z%26%23xA0%3B%20%3A%20Vol%202%20Drugs%2C%20Herbs%2C%20Nutrition%20and%20Supplements.%20Cham%3A%20Springer%20International%20Publishing%3B%202022.%20p.%20133%26%23x2013%3B9.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Ketoconazole%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Konstantinos%22%2C%22lastName%22%3A%22Anastassakis%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Konstantinos%22%2C%22lastName%22%3A%22Anastassakis%22%7D%5D%2C%22abstractNote%22%3A%22Ketoconazole%20is%20an%20antifungal%20agent%2C%20which%20belongs%20to%20the%20group%20of%20azoles%20%28imidazole%29%20%5B1%5D%2C%20was%20discovered%20in%201976%20by%20Janssen%20Pharmaceutica%2C%20and%20was%20first%20introduced%20in%201977.%20Ketoconazole%20has%20a%20prominent%20place%20in%20Clinical%20Dermatology%2C%20as%20the%20first%20orally-active%20antifungal%20azole%2C%20used%20both%20orally%20and%20topically%20to%20combat%20numerous%20types%20of%20moderate%20or%20severe%20fungal%20infections.%20Ketoconazole%20has%20mostly%20been%20replaced%20as%20a%20first-line%20systemic%20antifungal%20by%20other%20azole%20antifungal%20agents%2C%20such%20as%20Itraconazole%2C%20because%20of%20Ketoconazole%5Cu2019s%20higher%20toxicity%2C%20lower%20absorption%2C%20and%20more%20limited%20spectrum%20of%20activity.%20These%20properties%20are%20extensively%20covered%20in%20the%20relevant%20bibliography%20%5B2%5D%20and%20will%20not%20be%20analyzed%20further%20herein.%20This%20chapter%20will%20focus%20on%20the%20antiandrogenic%20and%20anti-inflammatory%20properties%20of%20Ketoconazole.%22%2C%22bookTitle%22%3A%22Androgenetic%20Alopecia%20From%20A%20to%20Z%20%20%3A%20Vol.%202%20Drugs%2C%20Herbs%2C%20Nutrition%20and%20Supplements%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22en%22%2C%22ISBN%22%3A%229783031080579%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-06T15%3A57%3A36Z%22%7D%7D%2C%7B%22key%22%3A%225VXPQES7%22%2C%22library%22%3A%7B%22id%22%3A11711645%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Anastassakis%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAnastassakis%20K.%20Shampoos%20and%20AGA%5C%2FFPHL.%20In%3A%20Anastassakis%20K%2C%20editor.%20Androgenetic%20Alopecia%20From%20A%20to%20Z%3A%20Vol3%20Hair%20Restoration%20Surgery%2C%20Alternative%20Treatments%2C%20and%20Hair%20Care.%20Cham%3A%20Springer%20International%20Publishing%3B%202023.%20p.%20761%26%23x2013%3B4.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Shampoos%20and%20AGA%5C%2FFPHL%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Konstantinos%22%2C%22lastName%22%3A%22Anastassakis%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Konstantinos%22%2C%22lastName%22%3A%22Anastassakis%22%7D%5D%2C%22abstractNote%22%3A%22Except%20for%20the%20Ketoconazole%202%25%20shampoo%2C%20no%20other%20pharmaceutical%20or%20ordinary%20shampoo%20possesses%20any%20true%20hair%20growth%20potential%2C%20and%20this%20should%20be%20clearly%20explained%20to%20all%20AGA%5C%2FFPHL%20patients.Sebum%20contains%20androgens%2C%20DHT%2C%20and%20IL-1%5Cu03b1%2C%20which%20are%20reabsorbed%20by%20hair%20follicles%20and%20perpetuate%20the%20androgen%20and%20inflammatory%20effects%20on%20hair%20follicles.%20Thus%20sebum%20removal%20thorough%20washing%20is%20necessary.Patients%20with%20AGA%5C%2FFPHL%20have%20increased%20scalp%20and%20hair%20cleansing%20needs%20since%20there%20is%20often%20increased%20seborrhea%2C%20product%20residues%2C%20and%20dryness%5C%2Fpeeling%20from%20Minoxidil%20Topical%20Solution%20or%20other%20topical%20hair%20growth%20products%20that%20need%20to%20be%20removed.Every%20treatment%20scheme%20against%20AGA%5C%2FFPHL%20should%20include%20Ketoconazole%202%25%2C%20shampoo%2C%20which%20must%20be%20used%20regularly%2C%20a%20mild%2C%20ordinary%20shampoo%2C%20and%20a%20conditioner.%20In%20every%20case%2C%20the%20physician%20should%20offer%20detailed%20instructions%20for%20proper%20use.%22%2C%22bookTitle%22%3A%22Androgenetic%20Alopecia%20From%20A%20to%20Z%3A%20Vol.3%20Hair%20Restoration%20Surgery%2C%20Alternative%20Treatments%2C%20and%20Hair%20Care%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22en%22%2C%22ISBN%22%3A%229783031106132%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222ER6MPEJ%22%5D%2C%22dateModified%22%3A%222024-05-06T15%3A57%3A49Z%22%7D%7D%5D%7D 1.
Borgers M, Van den Bossche H, De Brabander M. The mechanism of action of the new antimycotic ketoconazole. Am J Med. 1983 Jan 24;74(1B):2–8.
1.
Sawaya ME, Honig LS, Hsia SL. Increased androgen binding capacity in sebaceous glands in scalp of male-pattern baldness. J Invest Dermatol. 1989 Jan;92(1):91–5.
1.
Piérard-Franchimont C, De Doncker P, Cauwenbergh G, Piérard GE. Ketoconazole shampoo: effect of long-term use in androgenic alopecia. Dermatology. 1998;196(4):474–7.
1.
Khandpur S, Suman M, Reddy BS. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol. 2002 Aug;29(8):489–98.
1.
Hugo Perez BS. Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men. Med Hypotheses. 2004;62(1):112–5.
1.
Jiang J, Tsuboi R, Kojima Y, Ogawa H. Topical application of ketoconazole stimulates hair growth in C3H/HeN mice. J Dermatol. 2005 Apr;32(4):243–7.
1.
Inui S, Itami S. Reversal of androgenetic alopecia by topical ketoconzole: relevance of anti-androgenic activity. J Dermatol Sci. 2007 Jan;45(1):66–8.
1.
Aldhalimi MA, Hadi NR, Ghafil FA. Promotive Effect of Topical Ketoconazole, Minoxidil, and Minoxidil with Tretinoin on Hair Growth in Male Mice. International Scholarly Research Notices. 2014 Mar 9;2014:e575423.
1.
Fields JR, Vonu PM, Monir RL, Schoch JJ. Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review. Dermatol Ther. 2020 Jan;33(1):e13202.
1.
Anastassakis K. Ketoconazole. In: Anastassakis K, editor. Androgenetic Alopecia From A to Z : Vol 2 Drugs, Herbs, Nutrition and Supplements. Cham: Springer International Publishing; 2022. p. 133–9.
1.
Anastassakis K. Shampoos and AGA/FPHL. In: Anastassakis K, editor. Androgenetic Alopecia From A to Z: Vol3 Hair Restoration Surgery, Alternative Treatments, and Hair Care. Cham: Springer International Publishing; 2023. p. 761–4.